
NYSE:IBM
This summary was created by AI, based on 26 opinions in the last 12 months.
IBM's stock has faced significant volatility recently, highlighted by a 25% drop attributed to underwhelming comments on its AI initiatives. Experts suggest that, while the company has solid fundamentals and a strong presence in hybrid cloud and quantum computing, it has been viewed as 'dead money' in the past. The mixed reactions stem from worries over earnings misses affecting sentiment and revenue. Despite some analysts touting a long-term growth potential due to its strong positioning in critical software and AI, others caution against purchasing at current levels, citing technical weaknesses and macroeconomic factors contributing to its decline. The general outlook remains cautious with some proponents believing in a significant upside associated with its transformative journey, especially in technology adoption, despite notable short-term challenges.
We had these stocks that were growing off of AI, and they've been delivering spectacular growth. But they've also had spectacular increases in share prices, which becomes a potential source of volatility.
The question is whether valuations are too high given projected growth? As we've seen here, some of the price adjustments can be pretty abrupt.
Growing from multiple angles, yet valuation still reasonable. Stable and embedded business complemented by new growth drivers. Consulting business helps companies implement AI, and that's where the real spending is. Strong in hybrid cloud, managing data across environments. Quantum computing already being used with potential for energy, healthcare, manufacturing.
Drop in February due to sector rotation and profit taking. Trades ~19x PE, attractive. Sees 30% upside from here to ~$317. Yield is 2.85%.
Hold on to it. At 4-5% growth, in the ballpark of the top players. He doesn't know its exposure to robotics. Street's pretty positive on it, about 20% upside. At 20x PE, not an aggressive valuation. Margins expected to stay healthy -- 60% gross margins, net income margins of close to 20%.
(Analysts’ price target is $314.00)IBM Common Stock is a American stock, trading under the symbol IBM (previously IBM-N on Stockchase) on the New York Stock Exchange (IBM). It is usually referred to as NYSE:IBM or IBM
In the last year, 24 stock analysts issued a Buy, Sell, or Hold rating on IBM (previously IBM-N on Stockchase). 16 analysts recommended to BUY and 7 analysts recommended to SELL the stock. The latest stock analyst rating is WEAK BUY. Read the latest stock experts' ratings for IBM Common Stock.
IBM Common Stock was recommended as a Top Pick by Mike Vinokur, CFA, CMT, and CFP on 2026-08-04. Read the latest stock experts ratings for IBM Common Stock.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for IBM Common Stock.
IBM Common Stock is followed by 277 investors on Stockchase and is a trending stock that is worth watching.
On 2026-08-06, IBM Common Stock (IBM) stock closed at a price of $233.43.
They transition from hardware to services and software. The stock ran up on the hype leading the earnings, but then that enthusiasm vanished. Any revenue miss impacts earnings and sentiment. IBM is interesting in the long term, but IBM has been considered dead money in the past. You get a decent dividend and management is good.